Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

5-Cyclobutyl-5-Phenylhydantoin

    • Product Name 5-Cyclobutyl-5-Phenylhydantoin
    • Alias Phenytoin
    • Einecs 252-265-5
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    730089

    Chemical Name 5-Cyclobutyl-5-Phenylhydantoin
    Molecular Formula C13H14N2O2
    Molecular Weight 230.26 g/mol
    Cas Number 1186-76-7
    Appearance White to off-white solid
    Melting Point 186-190 °C
    Solubility In Water Slightly soluble
    Smiles O=C1NC(=O)C(c2ccccc2)(C3CCC3)N1
    Iupac Name 5-cyclobutyl-5-phenylimidazolidine-2,4-dione
    Storage Temperature Store at room temperature
    Synonyms CBPHD, 5-cyclobutyl-5-phenyl-2,4-imidazolidinedione

    As an accredited 5-Cyclobutyl-5-Phenylhydantoin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging is a sealed amber glass bottle containing 25 grams of 5-Cyclobutyl-5-Phenylhydantoin, labeled with hazard information and batch details.
    Shipping 5-Cyclobutyl-5-Phenylhydantoin is shipped in tightly sealed containers to prevent contamination and moisture exposure. It is packaged according to international regulations for chemicals, typically within secondary containment for added safety. The package is clearly labeled, with all hazard and handling instructions included, ensuring secure and compliant transportation.
    Storage **5-Cyclobutyl-5-Phenylhydantoin** should be stored in a tightly sealed container, protected from light, moisture, and sources of ignition. Keep it in a cool, dry, and well-ventilated area, preferably at room temperature (15–25°C). Segregate from incompatible substances such as strong oxidizing agents. Ensure appropriate labeling and restrict access to trained personnel only.
    Application of 5-Cyclobutyl-5-Phenylhydantoin

    Applications of 5-Cyclobutyl-5-Phenylhydantoin in Industrial Manufacturing

    As the original developer and manufacturer of 5-Cyclobutyl-5-Phenylhydantoin, we supply this specialized hydantoin derivative into a select set of advanced industry segments where its properties meet critical formulation and performance needs. Below you will find detailed application scenarios found in pharmaceutical, biomedical polymer, anticonvulsant research, and chemical synthesis sectors, each with focused industrial context.

    1. Active Pharmaceutical Ingredient (API) Manufacturing for Antiepileptic Medications

    Our hydantoin derivative is integrated into the synthesis of anticonvulsant APIs, particularly in advanced stages of generic and new chemical entity (NCE) development targeting partial and generalized seizure disorders. Pharmaceutical companies utilize this compound for its cyclobutyl-phenyl structure, supporting the creation of novel hydantoin-class APIs under stringent regulatory protocols and process controls. Formulation departments work closely with quality assurance to guarantee reproducibility and regulatory acceptance through every step from intermediate to finished dosage forms.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • US FDA 21 CFR Parts 210/211
    • EU EMA Guideline on the chemistry of active substances
    • USP/NF monograph requirements for hydantoin derivatives where applicable

    Typical usage ratio

    • Input as an intermediate: 0.8–1.5 molar equivalents against the target parent ring in stepwise condensation; actual input ratio refined based on route efficiency and impurity controls in process validation batches

    Downstream process integration

    • Fed into the mid-stage or late-stage synthesis stage within multipurpose reaction vessels; direct involvement in condensation and crystallization steps prior to final API purification

    Final product types

    • Anticonvulsant tablets and capsules
    • Bulk active pharmaceutical ingredient (API) powders for solid form manufacturing
    • Stabilized injectable anticonvulsants (solution and lyophilized forms)

    2. Biomedical Polymer Synthesis for Drug Delivery Systems

    Polymer engineers use 5-Cyclobutyl-5-Phenylhydantoin as a functional copolymer monomer or cross-linking agent for biomedical polymers, especially where controlled drug release profiles are desired. Its unique cyclic structure introduces degradable hydantoin linkages within biocompatible matrices, affecting in vivo hydrolysis rates and release kinetics. Quality control emphasizes analytical verification of incorporation rates and absence of residual monomer in medical-grade polymers, supporting compliance and batch-to-batch reproducibility.

    Industry compliance standards

    • ISO 10993-5 Biological evaluation of medical devices
    • USP <881> and <1031> for biocompatibility and polymer performance
    • FDA 21 CFR 820 Quality System Regulation for medical devices
    • REACH Annex XIV/EC 1907/2006 for safe monomer handling

    Typical usage ratio

    • Functionalization rate: 0.5–3% by weight in block copolymer blends, tailored to matrix backbone composition and desired degradation profile; subject to optimization during pilot and process qualification runs

    Downstream process integration

    • Added to reactor during prepolymer or solution-polymerization stages, typically after initiator charging and prior to chain-extension or cross-linking; monitored in situ by real-time NMR for copolymer incorporation efficiency

    Final product types

    • Bioresorbable implant coatings
    • Long-acting depot injection matrices
    • Microsphere and nanosphere drug carriers for targeted delivery

    3. Research and Development of Anticonvulsant Lead Compounds

    Drug discovery laboratories employ our compound as a scaffold for structure-activity relationship (SAR) exploration in medicinal chemistry programs. The ability to chemically derivatize the cyclobutyl and phenyl positions enables R&D teams to generate optimized molecules with improved CNS profiles for in vitro and in vivo animal testing. Procedural controls are critical to trace impurity development and confirm structure identity across multi-step syntheses where this intermediate is essential.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP)
    • Guidance for Industry: INDs for Phase 0 Exploratory Investigational New Drug Studies (FDA)
    • ICH Q2 (R1) validation of analytical procedures
    • All experiments performed within local safety and environmental regulations (e.g., OSHA Laboratory Standard, CLP Regulation (EC) No 1272/2008)

    Typical usage ratio

    • Precursor feed: 1.0 molar equivalent per desired hydantoin analog produced, adjusted within 5–10% based on coupling and substitution reaction efficiency

    Downstream process integration

    • Employed at lead optimization stage in medicinal chemistry, serving as the core scaffold during multi-step ISOL (isolation) and purification steps with flash chromatography and preparative HPLC to ensure high-purity lead outputs

    Final product types

    • Research-grade hydantoin analogs (mg–g scale) for in vitro/in vivo profiling
    • Reference standards and control compounds for pharmacokinetic testing

    4. Specialty Intermediate for Custom Chemical Synthesis

    Chemical process developers leverage this hydantoin intermediate for constructing specialty molecules containing cyclic and aromatic structures. The substrate’s rigid cyclobutyl ring and electron-rich phenyl group make it a valued building block for library synthesis in fine chemical and contract manufacturing projects where high-purity scaffolds are required for further functionalization. Documentation of traceability, lot segregation, and impurity profiling is maintained in accordance with project QC directives.

    Industry compliance standards

    • ISO 9001:2015 certified batch manufacturing practices
    • EU REACH Regulation for intermediate registration (EC 1907/2006)
    • In-process GMP as per customer-agreed quality technical agreements
    • Customer-mandated analytical method validation (HPLC, NMR, GC-MS, etc.)

    Typical usage ratio

    • Inserted at 0.1–1.2 molar equivalents according to the targeted downstream core motif; precise ratio determined by project-specific synthetic scheme and side-product minimization

    Downstream process integration

    • Reaction charging occurs during the core skeleton assembly step, serving as a nucleophile or condensation substrate, followed by direct downstream derivatization or cyclization under controlled temperature and solvent conditions

    Final product types

    • Custom pharmaceutical linkers or synthons
    • High-value research reagents for academic and industrial R&D
    • Precursor compounds for agrochemical and specialty materials sectors (used under contract or pre-approval agreements)
    Free Quote

    Competitive 5-Cyclobutyl-5-Phenylhydantoin prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    5-Cyclobutyl-5-Phenylhydantoin: A Closer Look at a Distinctive Hydantoin

    An Introduction Forged in Manufacturing Experience

    In the realm of specialty chemicals, 5-cyclobutyl-5-phenylhydantoin stakes a unique claim. This compound, crafted by hands that have spent years fine-tuning synthesis routes and batch consistency, has captured the attention of chemists looking for both dependability and performance in their intermediates. Within our manufacturing labs, familiarity with hydantoin derivatives runs deep, and the contrasting behaviors of different 5-substituted variants stand out clearly after repeated runs. The cyclobutyl-phenyl arrangement in this molecule doesn’t just look interesting on paper—its attributes in real-world applications have brought real-world benefits to research and production teams for quite some time.

    Model and Specifications: Shaped by Practical Insight

    Early work with hydantoins exposed us to the subtleties of crystal forms and handling properties. On the production line, we look for optimal flow, non-hygroscopicity, and thermal resilience. 5-cyclobutyl-5-phenylhydantoin has always delivered solid performance: its solid, white powder form resists clumping, which assists operators during both discharge from reactors and secondary packaging. Melting point and purity—measured by our in-house HPLC and NMR—consistently clear the 99% mark, as confirmed by years of scale-up trials and third-party cross-validation. Typical batch sizes span from small R&D quantities of several hundred grams to multi-kilogram lots destined for pharmaceutical or fine chemical synthesis.

    Physical handling marks one difference from some other hydantoin derivatives. The cyclobutyl moiety imparts structure, reducing dust and making transfer both safer and cleaner for the people working with the material. Solubility in common laboratory and process solvents counts as another operational plus. Over the years, our direct experience has shown minimal issues with sediment or unexpected reactivity in solvents such as acetonitrile, dimethylformamide, and DMSO.

    Key Usage Contexts: Wisdom Earned on the Factory Floor

    Looking back at production records and feedback from our partners in pharmaceuticals and materials science, we see clear trends in how 5-cyclobutyl-5-phenylhydantoin gets used. Medicinal chemists often turn to this compound when exploring hydantoin-based scaffolds for anticonvulsant and cardiovascular agents. The cyclic and aromatic substitutions extend molecular diversity, letting researchers probe regions of chemical space that simpler hydantoins can’t reach. Our own R&D team has observed how the cyclobutyl group influences metabolic stability compared to the methyl or ethyl alternatives—an insight that has shaped hundreds of research projects.

    Another area where this compound stands out involves its role as a building block for creating fused ring systems and bioisosteres. Both academic groups and industrial clients have credited the compound’s reliability during ring-closing or functional group transformation steps. Process chemists appreciate that scale-up rarely brings nasty surprises. Yields remain robust, and isolation from reaction mixtures requires no exotic equipment—a factor that’s especially valuable for fast-moving projects under time pressure.

    Differences from Other Hydantoin Products: Observations from Long-Term Production

    One of the real privileges in manufacturing is seeing how subtle structural tweaks affect performance. The cyclobutyl-phenyl combination occupies a realistic compromise between rigidity and lipophilicity that neither dialkyl-substituted hydantoins nor simple aryl variants can quite match. Many customers started with plain 5,5-diphenylhydantoin years ago, only to request our cyclobutyl-phenyl grade as soon as metabolic and pharmacokinetic data suggested a benefit.

    Operationally, some hydantoin analogs show batch-to-batch variability in color, flow, and purity, particularly at larger scales. In our practice, 5-cyclobutyl-5-phenylhydantoin consistently avoids off-spec issues. Its physical uniformity helps the plant team keep throughput up, and avoids the re-work that disrupts schedules and erodes trust with our buyers. Over the years, this reliability has trimmed lost time both in our own facility and that of customers.

    Synthesis routes for hydantoins vary with substituents. The cyclobutyl group needs careful control during alkylation and protection steps. Our investment in process control—monitoring temperature, reagent grade, and reaction times—has minimized impurities. Sometimes manufacturers of similar compounds run into problems like dimerization or off-pathway byproducts. By maintaining both strict analytical protocols and detailed batch history records, we have regularly delivered lots with impurity profiles suitable for even the most demanding medicinal chemistry uses.

    Supporting Chemists and Process Engineers on Both Sides of the Bench

    Every time we produce and pack 5-cyclobutyl-5-phenylhydantoin, the end-use scenarios stay present in our minds. Pharmaceutical teams depend on reproducibility, seeking to minimize variability in every round of screening and scale-up. Years of collaborative work with external and in-house chemists have taught us just how quickly a change in batch performance can derail project timelines. Our ongoing dialogue with users—rather than simply filling orders—shapes how we interpret lab data, respond to troubleshooting requests, and share best practices.

    One example involves differences in recrystallization outcomes based on subtle variations in solvent temperature or atmosphere. We’ve spent days running parallel batches, speaking directly with client technical teams, and sharing data in real time to nail down optimal conditions. That hands-on approach, from raw material selection through to shipment, shapes all our operating protocols and product release decisions.

    Beyond Bench Chemistry: Addressing Supply Chain and Handling Realities

    Behind every successful batch of 5-cyclobutyl-5-phenylhydantoin stands a set of supply realities. While we invest in high-grade starting materials, our team knows that disruptions upstream can cause headaches if the synthesis window isn’t tightly managed. Experience has taught us to maintain buffer stocks of critical raw compounds and build relationships with trusted suppliers. These habits aren’t the glamorous part of chemical manufacturing, but they keep projects moving even during wider market turbulence.

    On the shipping and warehousing side, our logistics crew—many with a decade or more tenure—inspects all packaging for moisture, impact, and contamination risks. Feedback from clients occasionally drives tweaks in container selection, allowing for easier decanting and improved shelf-life. Our on-site QC staff verifies identity and purity before release and can perform stability tests under client-specific conditions upon request.

    Troubleshooting and Quality Assurance: Lessons Learned Batch by Batch

    Even the best-run operations see the occasional hiccup. The practical knowledge base we’ve built around this compound lets us respond rapidly. Deviations in color or texture prompt a deep dive into both the upstream and downstream steps. Operator notes—often hand-written and detailed—help retrace each step, making it easier to pinpoint root causes, whether it’s a hangup in crystallization, filtration, or drying.

    Our approach to quality assurance evolved through these investigative routines. All analytical data is double-checked against lot-specific historical trends. Outliers prompt immediate shutdown and investigation, not a wave through to the next stage. For the rare customer complaint, we use retained samples and backup data to replicate conditions and provide more than boilerplate answers. Failures are learning opportunities: they reshape our processes and inform technical documentation that goes out with every shipment.

    Health, Safety, and Responsible Operations: More than Paper Compliance

    Daily handling of 5-cyclobutyl-5-phenylhydantoin puts responsibility for people and environment front and center. Operators in our plant rely on validated SOPs for chemical transfer, protective equipment, and spill response. Our plant safety officer leads regular training on risk mitigation that blends regulatory requirements with hard-won, real-world experience. Few things sharpen safety culture like a near-miss, so incident sharing and collaborative root cause analysis underpin every lesson written into our protocols.

    Hazard analysis draws from both published toxicology and accumulated anecdotes from front-line staff. We install real-time air monitoring in stations with high traffic and track solvent exposure via both electronic logs and staff feedback. All waste, including mother liquors and contaminated disposables, follows designated routes for recycling or final disposal. Ongoing dialogue with local regulators keeps our plant in sync with the latest standards and emerging best practices.

    Continuous Improvement: Listening and Learning from Partners

    Much of what we’ve learned about 5-cyclobutyl-5-phenylhydantoin came from close listening. Customers describe solubility quirks or shelf-life problems; researchers report reactivity nuances not captured in literature; our own batch operators troubleshoot unexpected heat evolution or crystallization challenges on the spot. This two-way information flow drives regular updates in operational controls and technical notes. The most compelling improvements rarely come from the boardroom—they accrue through practical input from experienced chemists and plant staff alike.

    Field visits and technical exchanges, whether on virtual platforms or inside customer facilities, reveal real applications and real-world obstacles. By taking time to observe these contexts, we’ve adjusted drying times, container linings, and recommended storage practices to match needs as they exist—not as imagined from a distance. Our conviction: good manufacturing depends as much on conversation and curiosity as it does on stainless steel and analytical reports.

    Navigating Scientific Advances and Regulatory Developments

    The hydantoin sector remains dynamic. Regulatory agencies update guidance on impurities, process safety, and end-use restrictions. Innovations in synthesis and purification emerge from across the globe. Staying current means both tracking new journal articles and cooperating with peer manufacturers on gray-area topics. If questions arise about heavy metals, particulates, or stereochemical purity, our team consults internal records and external experts to reach data-driven, transparent responses.

    We routinely scan regulatory horizons to anticipate shifts in demand or compliance needs. Sometimes that means enhancing our cleaning protocols or installing new air-handling infrastructure. Other times, it requires targeting more granular impurity profiles or working with customers to redesign supply arrangements for traceability. Direct engagement with regulatory agencies, auditors, and industry think-tanks helps keep our practices aligned with broader expectations.

    Practical Challenges and Forward-looking Solutions

    Working directly on the manufacturing line brings awareness not just of technical variables, but of human and institutional realities. Training new staff to handle specialty chemicals like 5-cyclobutyl-5-phenylhydantoin takes time and patient supervision. Missteps during transfer, mislabeling, or incorrect solvent use persist as perennial threats to product quality. Countering these risks demands a culture of constant learning, supported by open-door communication, regular process audits, and opportunities for direct feedback. Retention of experienced hands improves outcomes more than any software or gadget ever could.

    Anticipating future needs will involve balancing scale-up ambitions and tailored applications with our longstanding strengths: transparency, reliability, and responsive collaboration. As synthetic routes evolve and demand patterns shift, we commit to maintaining robust supply and support. Rather than chasing every market fad, we aim for the steady hand and clear voice that seasoned manufacturers bring to long-term partnerships.

    Why Experience Matters

    Reflecting on years with 5-cyclobutyl-5-phenylhydantoin, it’s clear that every specification sheet, certificate of analysis, or batch record represents a tapestry of hard-won knowledge and ongoing commitment to quality. The compound’s nuanced differences from other hydantoins we produce have emerged not from advertising prowess, but from daily realities—kilogram at a time—where even small tweaks can change outcomes for chemists and companies alike.

    In all, our real job goes beyond just putting molecules in a drum. It’s about supporting breakthroughs in science, protecting the people and community around us, and building lasting bridges between academic curiosity and practical advancement. For every lot of 5-cyclobutyl-5-phenylhydantoin we ship, the quiet but essential work of dozens of hands ensures that customers count on both the molecule and the people behind it.